CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 
 

KMPH's Operating Income Growth by Quarter and Year

Kempharm Inc's Operating Income results by quarter and year




KMPH Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -2.84 -3.21 -4.41
III Quarter September -6.63 -2.22 -1.21 3.23
II Quarter June -24.77 5.83 2.59 -7.79
I Quarter March -1.86 6.96 -3.78 -11.37
FY   -33.26 7.73 -5.61 -20.34



KMPH Operating Income third quarter 2022 Y/Y Growth Comment
Kempharm Inc in the third quarter 2022 recorded Operating Loss of $ -6.63 millions.

According to the results reported in the third quarter 2022, Kempharm Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Kempharm Inc' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


KMPH Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - 125.1 % - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kempharm Inc's third quarter 2022 Operating Income $ -6.63 millions KMPH's Income Statement
Kempharm Inc's third quarter 2021 Operating Income $ -2.22 millions Quarterly KMPH's Income Statement
New: More KMPH's historic Operating Income Growth >>


KMPH Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - -16.24 % - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kempharm Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Operating Income Comment
Even if Kempharm Inc in the III. Quarter 2022 revealed Operating Loss of $ -6.63 millions, management said, that those numbers are recovery in contrast to the -24.77 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Kempharm Inc achieved highest sequential Operating Income growth. While Kempharm Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KMPH's III. Quarter Q/Q Operating Income Comment
Although Kempharm Inc in the III. Quarter 2022 showed Operating Loss of $ -6.63 millions, some analyst said, that current results are slight up side relative to the -24.77 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Kempharm Inc achieved highest sequential Operating Income growth. While Kempharm Inc's Operating Income growth quarter on quarter, overall rank is .


Kempharm Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -36.09 $ -31.69 $ -1.09 $ 7.73 $ 7.36
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - 5.06 % -12.06 %
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Kempharm Inc realized trailing twelve months Operating Loss of $ -36 millions, in the Sep 30 2022, compare to Operating Income of $ 7 millions a year ago.

Kempharm Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Kempharm Inc realized trailing twelve months Operating Loss of $ -36 millions, in the Sep 30 2022, compare to Operating Income of $ 7 millions a year ago.

Kempharm Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
KMPH's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for KMPH's Competitors
Operating Income Growth for Kempharm Inc's Suppliers
Operating Income Growth for KMPH's Customers

You may also want to know
KMPH's Annual Growth Rates KMPH's Profitability Ratios KMPH's Asset Turnover Ratio KMPH's Dividend Growth
KMPH's Roe KMPH's Valuation Ratios KMPH's Financial Strength Ratios KMPH's Dividend Payout Ratio
KMPH's Roa KMPH's Inventory Turnover Ratio KMPH's Growth Rates KMPH's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
The Pennant Group Inc 319.74%$ 319.741 millions
Dynavax Technologies Corporation282.11%$ 282.107 millions
Vaso Corporation281.76%$ 281.761 millions
Innoviva Inc 202.92%$ 202.924 millions
Pacific Health Care Organization Inc 149.86%$ 149.860 millions
American Shared Hospital Services140.86%$ 140.860 millions
3m Company132.44%$ 132.438 millions
Lsi Industries Inc 125.50%$ 125.495 millions
Msa Safety Inc122.07%$ 122.068 millions
Universal Security Instruments Inc120.59%$ 120.587 millions
Ethema Health Corporation 114.34%$ 114.335 millions
Carlisle Companies Incorporated109.13%$ 109.129 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DMAQ's Profile

Stock Price

DMAQ's Financials

Business Description

Fundamentals

Charts & Quotes

DMAQ's News

Suppliers

DMAQ's Competitors

Customers & Markets

Economic Indicators

DMAQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071